Exhaled nitric oxide: Still alive, not laid to rest

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 2, 2009, Pages 88-89

  Taylor, D Robin ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CORTICOSTEROID; NITRIC OXIDE;

ANXIETY; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DISEASE MARKER; EDITORIAL; EOSINOPHIL; EXPIRED AIR; GASTROESOPHAGEAL REFLUX; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; RHINOSINUSITIS; TREATMENT OUTCOME; VOCAL CORD DISORDER;

ADMINISTRATION, INHALATION; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; EXHALATION; GLUCOCORTICOIDS; HUMANS; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 58449123149     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200810-1605ED     Document Type: Editorial

References (15)

1. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007;176:231-237.
2. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163-2173.
3. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in asthmatic children: a randomized controlled trial. Am J Respir Crit Care Med 2005;23:23.
4. de Jongste JC, Carraro S, Hop WC, CHARISM Study Group, Baraldi, E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2008;179:93-97.
5. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008;372:1065-1072.
6. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-1721.
7. Olin AC, Bake B, Toren K. Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 2007;131:1852-1856.
8. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med 2005;172:453-459.
9. Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 2008;31:539-546.
10. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005;171:1077-1082.
11. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218-224.
12. Januzzi JL, Richards AM. An international consensus statement regarding amino-terminal pro-B-type natriuretic peptide testing: the International NT-proBNP Consensus Panel. Am J Cardiol 2008;101:Suppl.
13. Pavord ID, Shaw DE, Gibson PG, Taylor DR. Inflammometry to assess airway diseases. Lancet 2008;372:1017-1019.
14. Hewitt RS, Smith AD, Cowan JO, Schofield JC, Herbison GP, Taylor DR. Serial exhaled nitric oxide measurements in the assessment of laboratory animal allergy. J Asthma 2008;45:101-107.
15. Stick S. Inflammatory markers should be the basis of monitoring asthma: the case for the pro's. Paediatr Respir Rev 2006;7:S93-S95.